Does Glucagon-like Peptide (GLP-1) Receptor Agonist Stimulation Reduce Alcohol Intake in Patients With Alcohol Dependence
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Exenatide (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- Acronyms EXALT
- 06 Nov 2020 This trial is Discontinued (Global End Date: 06 Oct 2020), according to European Clinical Trials Database record.
- 06 Oct 2020 Status changed from active, no longer recruiting to completed.
- 08 Oct 2019 Planned primary completion date changed from 1 Apr 2020 to 15 Apr 2020.